Alto Neuroscience OverviewAlto Neuroscience EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ANRO.
Quarterly EBIT
-$27.14M
↓ 73.12% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$76.41M
↓ 12.74% YoY
Trailing 12 months ending Mar 31, 2026
Alto Neuroscience OverviewEBIT (Earnings Before Interest and Taxes) analysis for ANRO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026